Prevalence of the human papillomavirus (HPV) types among cervical dysplasia women attending a gynaecological clinic in Sweden
暂无分享,去创建一个
L. Engstrand | M. Olovsson | I. Schuppe-Koistinen | L. W. Hugerth | Alexandra A. L. Pennhag | Gabriella Edfeldt | Liqin Cheng | J. Du | Fabricio Romero García | Johanna Norenhag
[1] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[2] P. Lopalco,et al. The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019) , 2020, Expert review of vaccines.
[3] M. Poljak,et al. The European response to the WHO call to eliminate cervical cancer as a public health problem , 2020, International journal of cancer.
[4] Chengquan Zhao,et al. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory. , 2020, Journal of the American Society of Cytopathology.
[5] P. Sparén,et al. Impact of HPV vaccination on cervical screening performance: a population-based cohort study , 2020, British Journal of Cancer.
[6] S. Regauer,et al. Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study. , 2020, Gynecologic oncology.
[7] M. Karlsson,et al. Prevalence of HPV and pathological changes among women 70 years of age, 10 years after exclusion from the Swedish cervical cancer screening program , 2020, Cancer Causes & Control.
[8] Maria Hortlund,et al. Human papillomavirus types in cervical dysplasia among young HPV‐vaccinated women: Population‐based nested case–control study , 2019, International journal of cancer.
[9] R. Olsen,et al. HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests. , 2019, Journal of the American Society of Cytopathology.
[10] L. Engstrand,et al. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine , 2019, Front. Cell. Infect. Microbiol..
[11] Maria Hortlund,et al. Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention , 2019, Cancer medicine.
[12] S. Beddows,et al. The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010–2016 , 2018, The Journal of infectious diseases.
[13] T. Iftner,et al. Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers , 2017, Papillomavirus research.
[14] R. Winer,et al. Natural History of HPV Infection across the Lifespan: Role of Viral Latency , 2017, Viruses.
[15] A. Firenze,et al. Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily , 2017, Human vaccines & immunotherapeutics.
[16] J. Ordi,et al. HPV‐negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis , 2015, BJOG : an international journal of obstetrics and gynaecology.
[17] S. Franceschi,et al. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. , 2013, Virology.
[18] W. Tjalma,et al. Cervical cancer screening: which HPV test should be used--L1 or E6/E7? , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[19] M. Plummer,et al. Global burden of human papillomavirus and related diseases. , 2012, Vaccine.
[20] Peng Guan,et al. Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer , 2012, International journal of cancer.
[21] C. Rubio,et al. Prevalence of Human Papillomavirus (HPV) in Oesophageal Squamous Cell Carcinoma in Relation to Anatomical Site of the Tumour , 2012, PloS one.
[22] E. Lynge,et al. Introduction of human papillomavirus vaccination in Nordic countries. , 2012, Vaccine.
[23] P. Sparén,et al. Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15–23-year-old women attending a youth health clinic in Stockholm, Sweden , 2011, Scandinavian journal of infectious diseases.
[24] J. Dillner,et al. Introduction of human papillomavirus (HPV) vaccination in Sweden. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[25] S. Franceschi,et al. Human papillomavirus types in glandular lesions of the cervix: A meta‐analysis of published studies , 2013, International journal of cancer.
[26] The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. , 1989, JAMA.